Merck & Co., Inc. (MRK)
100.83
-1.44
(-1.41%)
USD |
NYSE |
Dec 04, 16:00
101.02
+0.19
(+0.19%)
After-Hours: 20:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 250.26B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | 4.14% |
| Valuation | |
| PE Ratio | 13.34 |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 3.976 |
| Price to Book Value | 4.827 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | 0.85 |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.798 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 43.45% |
Profile
| Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ. |
| URL | http://www.merck.com |
| Investor Relations URL | https://www.merck.com/investor-relations |
| HQ State/Province | New Jersey |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | Feb. 03, 2026 |
| Last Earnings Release | Oct. 30, 2025 |
| Next Ex-Dividend Date | Dec. 15, 2025 |
| Last Ex-Dividend Date | Sep. 15, 2025 |
Ratings
Profile
| Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ. |
| URL | http://www.merck.com |
| Investor Relations URL | https://www.merck.com/investor-relations |
| HQ State/Province | New Jersey |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | Feb. 03, 2026 |
| Last Earnings Release | Oct. 30, 2025 |
| Next Ex-Dividend Date | Dec. 15, 2025 |
| Last Ex-Dividend Date | Sep. 15, 2025 |